Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor-Reference-Cited by-同舟云学术

Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor

Published:2001-11 Issue:5 Volume:60 Page:1737-1744
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Ritter Cynthia S.,Finch Jane L.,Slatopolsky Eduardo A.,Brown Alex J.

Publisher

Elsevier BV

Subject

Nephrology

Reference27 articles.

1. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism;Kifor;J Clin Endocrinol Metabol,1996

2. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism;Gogusev;Kidney Int,1997

3. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure;Korkor;N Engl J Med,1987

4. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients;Fukuda;J Clin Invest,1993

5. Correlation of enhanced cell proliferation with decreased density of vitamin D receptor in parathyroid hyperplasia in chronic dialysis patients;Koike;Nephrology,1997

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Induction of Parathyroid Cell Differentiation from Human Induced Pluripotent Stem Cells Promoted Via TGF-α/EGFR Signaling;Stem Cells and Development;2023-11-01

2. Pharmacological profile of upacicalcet, a novel positive allosteric modulator of calcium-sensing receptor, in vitro and in vivo;European Journal of Pharmacology;2023-10

3. The role of calcium sensitive and vitamin D receptors in the pathogenesis of sporadic multiple parathyroid gland disease;Problems of Endocrinology;2023-06-30

4. Primary and secondary hyperparathyroidism present different expressions of calcium-sensing receptor;BMC Surgery;2023-02-08

5. Management of osteoporosis in patients with chronic kidney disease;Osteoporosis International;2022-06-24